FTNT vs STRO
Fortinet Inc (FTNT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the FTNT and STRO stock pages for the full models.
Not investment advice.